New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 17, 2014
10:12 EDTGNC, VSIGNC drops after analyst downgrades on sales concerns
Shares of vitamins and supplements retailer GNC (GNC) are falling after research firm Jefferies downgraded the stock to Hold from Buy in a note to investors today. WHAT'S NEW: The growth of vitamins and supplements sales appear to be slowing, as sales of the products were "flattish" in Q2 and rose only 1% through the four weeks ending July 5, wrote Jefferies analyst Mark Wiltamuth. Until recently, sales of the products had risen at a 6%-10% annual clip for years, the analyst reported. GNC will also face a hit following the FDA's crack down on a pre-workout supplement called DMAA, as the supplement accounted for 8% of the company's sales, Wiltamuth believes. Additionally, the company faces a tough comparison in Q2, as it launched its Gold Card discount plan in the second quarter of 2013, the analyst noted. Warning that GNC's comparative sales could drop in Q2 and Q3, Wiltamuth thinks anemic sales growth could hurt its margins. He slashed his price target on the name to $39 from $50. PRICE ACTION: In early trading, GNC shares fell 82c, or 2.3% to $34.78. One of GNC's competitors, Vitamin Shoppe (VSI), lost 0.7% to $42.72.
News For GNC;VSI From The Last 14 Days
Check below for free stories on GNC;VSI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2014
09:17 EDTVSI, GNCOn The Fly: Pre-market Movers
Subscribe for More Information
08:05 EDTGNCGNC Holdings sees FY14 EPS $2.85, consensus $3.03
Subscribe for More Information
08:04 EDTGNCGNC Holdings: Q2 reflects difficult environment with retail traffic challenges
Subscribe for More Information
08:03 EDTGNCGNC Holdings reports Q2 EPS 77c, consensus 79c
Subscribe for More Information
July 28, 2014
15:47 EDTGNCNotable companies reporting before tomorrow's open
Subscribe for More Information
07:36 EDTVSIVitamin Shoppe comps should should show acceleration, says RW Baird
Baird expects Q2 earnings at Vitamin Shoppe to be in-line but believes its comparable sales should show an acceleration and an improved margin performance relative to prior quarters. The firm also believes concerns over increased promotional activity are overblown. Baird likes the stock at current levels and keeps a Buy rating with a $55 price target on the shares.
July 21, 2014
06:19 EDTVSIVitamin Shoppe recommended ahead of Q2 report at Goldman
Goldman believes Vitamin Shoppe (VSI) competitive pressures are overblown and that the company has relatively low overlap with GNC (GNC) and that recent price cuts have had minimal impact. The firm expects Vitamin Shoppe's Q2 to mark the beginning of sharp earnings acceleration and better execution and recommends buying shares ahead of the Q2 report. Shares are rated Conviction Buy with a $60 price target.
July 17, 2014
10:12 EDTGNC, VSIGNC drops after analyst downgrades on sales concerns
Subscribe for More Information
10:00 EDTGNCOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: 21st Century Fox (FOXA) downgraded to Buy from Strong Buy at ISI Group... Charter (CHTR) downgraded to Hold from Buy at Jefferies... Covidien (COV) downgraded to Hold from Buy at Needham... Diageo (DEO) downgraded to Underweight from Neutral at JPMorgan... GNC Holdings (GNC) downgraded to Hold from Buy at Jefferies... International Game (IGT) downgraded to Market Perform from Outperform at BMO Capital... JAVELIN Mortgage (JMI) downgraded to Market Perform from Outperform at JMP Securities... Macquarie Group (MQBKY) downgraded to Underweight from Neutral at JPMorgan... PNC Financial (PNC) downgraded to Neutral from Buy at Compass Point... PetSmart (PETM) downgraded to Sector Perform from Outperform at RBC Capital... Rexam (REXMY) downgraded to Hold from Buy at Deutsche Bank.
07:16 EDTGNCGNC Holdings downgraded to Hold from Buy at Jefferies
Jefferies downgraded GNC Holdings to Hold citing a slowdown in industry sales trends and risk of near-term earnings disappointments. The firm lowered its price target for shares to $39 from $50.
05:30 EDTGNCGNC Holdings downgraded to Hold from Buy at Jefferies
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use